Showing results (251-260 of 301) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|September 19, 2025
Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) AssessmentsKanoko Goto, Aya Hariu, Ryosuke KuribayashiPharmaceutical Medicine|December 5, 2017
Medicines Regulation in Africa: Current State and OpportunitiesMargareth Ndomondo-Sigonda, Jacqueline Miot, Shan Naidoo, et al.Pharmaceutical Medicine|October 24, 2017
Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified RisksMakoto Fujikawa, Shunsuke OnoPharmaceutical Medicine|January 17, 2023
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature ReviewNaohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, et al.Pharmaceutical Medicine|June 7, 2022
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical PracticeAjeet Gajra, Abigail Zalenski, Aishwarya Sannareddy, et al.Pharmaceutical Medicine|December 28, 2020
Building a Data Linkage Foundation for Mother-Child Pharmacoepidemiology ResearchChristine C Whitmore, R Eric Hawley, Jea Young Min, et al.Pharmaceutical Medicine|July 15, 2021
The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position PaperStefne Pienaar, Sarah Dunnett, Angela Flores, et al.Pharmaceutical Medicine|May 19, 2022
The Impact of the Priority Review Voucher on Research and Development for Tropical DiseasesCeline Aerts, Eliana Barrenho, Marisa Miraldo, et al.Pharmaceutical Medicine|January 16, 2021
Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019Katherine A P Zagrodney, Natasha Y Sheikhan, Ashlyn Pinto, et al.Pageof 31